Published in Environ Geochem Health on June 16, 2013
Health risk assessment of heavy metals and metalloid in drinking water from communities near gold mines in Tarkwa, Ghana. Environ Monit Assess (2015) 0.88
Accumulation of Heavy Metals and Metalloid in Foodstuffs from Agricultural Soils around Tarkwa Area in Ghana, and Associated Human Health Risks. Int J Environ Res Public Health (2015) 0.87
Heavy metal accumulation in soils and grains, and health risks associated with use of treated municipal wastewater in subsurface drip irrigation. Environ Monit Assess (2015) 0.86
Heavy metals contamination and human health risk assessment around Obuasi gold mine in Ghana. Environ Monit Assess (2016) 0.78
Different Choices of Drinking Water Source and Different Health Risks in a Rural Population Living Near a Lead/Zinc Mine in Chenzhou City, Southern China. Int J Environ Res Public Health (2015) 0.78
Human health risk assessment via drinking water pathway due to metal contamination in the groundwater of Subarnarekha River Basin, India. Environ Monit Assess (2015) 0.75
Health risk estimates for groundwater and soil contamination in the Slovak Republic: a convenient tool for identification and mapping of risk areas. Environ Geochem Health (2014) 0.75
Chemical sequential extraction for metal partitioning in environmental solid samples. J Environ Monit (2002) 1.98
Arsenic risk assessment. Environ Health Perspect (1994) 1.47
Human health risk assessment case study: an abandoned metal smelter site in Poland. Chemosphere (2002) 1.42
Risk and revisionism in arsenic cancer risk assessment. Environ Health Perspect (1995) 1.35
Heavy metal contaminations in a soil-rice system: identification of spatial dependence in relation to soil properties of paddy fields. J Hazard Mater (2010) 1.24
Monitoring of contaminated toxic and heavy metals, from mine tailings through age accumulation, in soil and some wild plants at Southeast Egypt. J Hazard Mater (2010) 1.00
Health risks associated with contamination of groundwater by abandoned mines near Twisp in Okanogan County, Washington, USA. Environ Geochem Health (2004) 0.83
Organophosphate Pesticide Residues in Drinking Water from Artesian Wells and Health Risk Assessment of Agricultural Communities, Thailand. Hum Ecol Risk Assess (2009) 0.83
Environmental risk assessment of arsenic and fluoride in the Chaco Province, Argentina: research advances. J Toxicol Environ Health A (2012) 0.83
Nickel(II)-induced oxidative stress, apoptosis, G2/M arrest, and genotoxicity in normal rat kidney cells. J Toxicol Environ Health A (2010) 0.81
Health risk assessment maps for arsenic groundwater content: application of national geochemical databases. Environ Geochem Health (2007) 0.81
Effect of pH on transport of Pb2+, Mn2+, Zn2+ and Ni2+ through lateritic soil: column experiments and transport modeling. J Environ Sci (China) (2011) 0.76
Health risk assessment of inorganic arsenic intake of Ronphibun residents via duplicate diet study. J Med Assoc Thai (2009) 0.76
Arsenic residues in well water 36 y after endemic arsenic poisoning. Arch Environ Health (2000) 0.76
Assessment of heavy metal exposure via the intake of oriental medicines in Korea. J Toxicol Environ Health A (2009) 0.76
Toxic levels of some heavy metals in drinking groundwater in Dakahlyia Governorate, Egypt in the year 2010. Int J Occup Environ Med (2011) 0.76
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet (2010) 9.72
Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med (2015) 4.77
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2002) 3.25
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol (2002) 2.80
Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. Oncology (Williston Park) (2010) 2.42
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med (2013) 2.37
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res (2003) 2.32
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer. J Clin Oncol (2008) 2.28
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clin Cancer Res (2002) 2.16
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev (2011) 1.99
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol (2003) 1.62
Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Clin Cancer Res (2010) 1.58
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med Genet (2003) 1.43
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J Natl Cancer Inst (2003) 1.42
The place for politics? Lancet (2003) 1.38
A comparison of bilateral breast cancers in BRCA carriers. Cancer Epidemiol Biomarkers Prev (2005) 1.27
Revealing the incidentalome when targeting the tumor genome. JAMA (2013) 1.27
Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst (2009) 1.26
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res (2011) 1.22
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? Breast Cancer Res Treat (2013) 1.16
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
The 6q22.33 locus and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat (2006) 1.11
NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement. J Natl Compr Canc Netw (2011) 1.10
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. PLoS Genet (2013) 1.10
Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Crit Rev Oncol Hematol (2006) 1.09
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat (2012) 1.09
Chlorpyrifos accumulation patterns for child-accessible surfaces and objects and urinary metabolite excretion by children for 2 weeks after crack-and-crevice application. Environ Health Perspect (2005) 1.07
Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Ann Surg Oncol (2013) 1.01
Leprosy: steps along the journey of eradication. Public Health Rep (2008) 1.01
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers. Oncogene (2002) 1.00
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res (2014) 0.99
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat (2012) 0.98
Perinatal exposure to perchlorate. thiocyanate, and nitrate in New Jersey mothers and newborns. Environ Sci Technol (2009) 0.98
Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Cancer J (2010) 0.98
Agricultural Pesticide Management in Thailand: Situation and Population Health Risk. Environ Sci Policy (2012) 0.97
Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am (2010) 0.97
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev (2006) 0.96
Genotoxic monitoring and benzene exposure assessment of gasoline station workers in metropolitan Bangkok: sister chromatid exchange (SCE) and urinary trans, trans-muconic acid (t,t-MA). Asian Pac J Cancer Prev (2011) 0.95
Hereditary ovarian cancer in Ashkenazi Jews. Fam Cancer (2004) 0.91
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer. J Clin Oncol (2009) 0.91
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers. Clin Cancer Res (2002) 0.90
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Res (2013) 0.90
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer (2013) 0.90
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2014) 0.89
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer (2012) 0.89
Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic? BMC Med (2014) 0.89
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc (2006) 0.88
Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study. Cancer (2003) 0.88
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update. Breast Cancer Res Treat (2008) 0.87
Rare de novo germline copy-number variation in testicular cancer. Am J Hum Genet (2012) 0.87
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer. Clin Cancer Res (2011) 0.86
BRCA mutations in women with ductal carcinoma in situ. Clin Cancer Res (2007) 0.85
Methodologies to examine the importance of host factors in bioavailability of metals. Ecotoxicol Environ Saf (2003) 0.84
The impact of environmental factors on nursing stress, job satisfaction, and turnover intention. J Nurs Adm (2010) 0.83
Assessment of SLX4 Mutations in Hereditary Breast Cancers. PLoS One (2013) 0.82
Inhalation exposure of organophosphate pesticides by vegetable growers in the Bang-Rieng subdistrict in Thailand. J Environ Public Health (2010) 0.82
Inherited predisposition to gastrointestinal stromal tumor. Hematol Oncol Clin North Am (2009) 0.82
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds. Fam Cancer (2005) 0.82
Germline EGFR T790M mutation found in multiple members of a familial cohort. J Thorac Oncol (2014) 0.81
Perchlorate exposure in lactating women in an urban community in New Jersey. Sci Total Environ (2010) 0.79
Children's residential exposure to chlorpyrifos: application of CPPAES field measurements of chlorpyrifos and TCPy within MENTOR/SHEDS-Pesticides model. Sci Total Environ (2005) 0.79
Organizational factors and office workers' health after the World Trade Center terrorist attacks: long-term physical symptoms, psychological distress, and work productivity. J Occup Environ Med (2008) 0.79
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible. Clin Breast Cancer (2008) 0.79
Health risk reduction behaviors model for scavengers exposed to solid waste in municipal dump sites in Nakhon Ratchasima Province, Thailand. Risk Manag Healthc Policy (2012) 0.78
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer. Clin Cancer Res (2007) 0.78
Assessing and improving bioterrorism preparedness among first responders: a pilot study. J Environ Health (2007) 0.78
Mercury vapor in residential building common areas in communities where mercury is used for cultural purposes versus a reference community. Sci Total Environ (2008) 0.78
Pesticides and other chemicals: minimizing worker exposures. J Agromedicine (2010) 0.77
Analytical method developed for measurement of dialkylphosphate metabolites in urine collected from children non-occupationally exposed to organophosphate pesticides in an agricultural community in Thailand. Bull Environ Contam Toxicol (2008) 0.77
Multi-approach model for improving agrochemical safety among rice farmers in Pathumthani, Thailand. Risk Manag Healthc Policy (2012) 0.77
Organophosphate pesticide exposure in school-aged children living in rice and aquacultural farming regions of Thailand. J Agromedicine (2014) 0.76
Adaptation of a neurobehavioral test battery for Thai children. Rocz Panstw Zakl Hig (2014) 0.76
Respiratory symptoms and patterns of pulmonary dysfunction among roofing fiber cement workers in the south of Thailand. J Occup Health (2012) 0.76
Evaluation of an innovative use of removable thin film coating technology for the abatement of hazardous contaminants. J Occup Environ Hyg (2009) 0.75
What women with breast cancer discuss with clinicians about risk for their adolescent daughters. J Psychosoc Oncol (2012) 0.75
Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation? J Clin Oncol (2011) 0.75
ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PRACTICE ON USING OF PERSONAL PROTECTIVE EQUIPMENT IN RATTAN CRAFTSMEN AT TRADE VILLAGE, KIENXUONG DISTRICT, THAIBINH PROVINCE, VIETNAM. Warasan Wichai Witthayasat Kanphaet (2009) 0.75
Hepatic metallothionein and Glutathione-S-Transferase responses in two populations of rice frogs, Fejervarya limnocharis, naturally exposed to different environmental cadmium levels. Bull Environ Contam Toxicol (2012) 0.75
Occupational noise-induced hearing loss in auto part factory workers in welding units in Thailand. J Occup Health (2016) 0.75
Genetic predisposition to cancer. Preface. Hematol Oncol Clin North Am (2010) 0.75
Participatory ergonomics intervention for improving work-related musculoskeletal disorders in the 'One Tambon One Product' industry in Thailand. J Hum Ergol (Tokyo) (2011) 0.75
Organophosphate pesticide exposure and dialkyl phosphate urinary metabolites among chili farmers in northeastern Thailand. Rocz Panstw Zakl Hig (2014) 0.75
Health risk assessment related to dermal exposure of chlorpyrifos: a case study of rice growing farmers in Nakhon Nayok Province, Central Thailand. J Agromedicine (2014) 0.75
Vulnerability assessment of New Jersey's food supply to invasive species: the New Jersey IMPORT project. New Solut (2006) 0.75